Marion McCourt, EVP Commercial at REGENERON PHARMACEUTICALS, INC. (REGN), sold 358 shares at $967.50 ($346K) on 2024-03-01, disclosed to the SEC on 2024-03-05.
Scheduled sale ($346k) by EVP Commercial under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| REGN | SELL | 2024-10-03 | $1.1M | — | Filing → |
| REGN | SELL | 2024-09-05 | $1.2M | — | Filing → |
| REGN | SELL | 2024-08-05 | $2.4M | — | Filing → |